FDA approves Kala's twice-daily ocular steroid

Kala Pharmaceuticals Inc. (NASDAQ:KALA) said FDA approved Inveltys (KPI-121 1%) to treat post-operative inflammation

Read the full 142 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE